NEW YORK (GenomeWeb) – The National Institutes of Health plans has awarded six clinical research institutions $43 million to create a National Human Genome Research Institute-led network that will use genomic medicine to investigate rare and undiagnosed diseases.

NHGRI said today the funding for the Undiagnosed Diseases Network, provided by the NIH Common Fund, expands the Undiagnosed Diseases Program that has been running at the NIH Clinical Center for six years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.